![](/img/cover-not-exists.png)
Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study
Taki, Kentaro, Koyanagi, Momoha, Nagaoka, Soshi, Shingaki, TomotakaJournal:
Current Medical Research and Opinion
DOI:
10.1080/03007995.2020.1834374
Date:
October, 2020
File:
PDF, 1.27 MB
2020